期刊文献+

恶性腹膜间皮瘤13例临床特点及诊治体会 被引量:9

Clinical analysis of 13 cases malignant peritoneal mesothelioma
下载PDF
导出
摘要 目的:探讨恶性腹膜间皮瘤的临床特点、诊断方法和治疗方法及预后。方法:对13例经病理证实的恶性腹膜间皮瘤临床病例进行回顾性分析。结果:13例恶性腹膜间皮瘤中,主要临床表现为腹胀9例(69.2%),腹痛6例(46.2%);主要体征为腹水11例(84.6%),腹部包块3例(27.3%);血、腹水肿瘤标记物升高、渗出性腹水及影像学提示腹膜及网膜增厚是常见的客观特征,误诊率高(8例,61.5%),确诊有赖于各种有创性方法获取病理证实。手术切除或行腹腔镜下减瘤术4例(30.8%),腹腔化疗8例(61.5%),全身化疗7例(53.8%),其中4例腹腔化疗联合全身化疗。本组中位生存期仅2.8个月。结论:该病临床表现缺乏特异性,诊断应尽早并尽可能取腹膜病理活检,治疗应采用以手术、全身及或局部化疗为主的综合治疗方法。 Objective: To study the clinical characteristic, diagnosis and treatment of malignant peritoneal mesothelioma. Methods:The clinical data of 13 patients with malignant peritoneal mesothelioma pathologically confirmed were retrospectively analyzed. Results:Of 13 cases, abdominal distension (9 cases) and abdominal pain(6 cases) were the main clinical features. Ascites ( 11 cases)and abdominal mass(3 cases) were key physical sign. Increasing tumor makers in blood and ascites, exudative ascites and thickening peritoneal were common features. The rate of misdiagnosis was 61.5% in this group. The final diagnosis depends on pathological examination by various means. Surgical resection was given in 4 patients, local abdominal cavity chemotherapeutic instillations in 8 patients, systemic chemotherapy in 7 patients (local combined systemic chemotherapy in 4 patients). The median time of survival was only 2. 8 months in this group. Conclusion : Due to unspecific clinical symptoms, malignant peritoneal mesothelioma's final diagnosis depends on pathological examination as early as possible. And treatment should be combined methods including operation, local and/or systemic chemotherapy.
出处 《临床肿瘤学杂志》 CAS 2008年第4期338-340,共3页 Chinese Clinical Oncology
关键词 恶性腹膜间皮瘤 诊断 治疗 Malignant peritoneal mesothelioma Diagnosis Therapy
  • 相关文献

参考文献7

  • 1Cocco P,Dosemeci M. Peritoneal cancer and occupational exposure toasbestos:resuhs from the application of a job-exposure matrix[ J]. AmJ lnd Med, 1999,35:9214.
  • 2Krasuski P, Poniecka A, Gal E. The diagnostic challenge of peritoneal mesothelioma [ J ]. Arch Gynecol Obstet, 2002,266 : 130 - 132.
  • 3Rich S, Presant CA, Meyer J, et al. Human chofionic gonadotropin and malignant mesothelioma[ J]. Cancer, 1979,43 (4) : 1457 - 1462.
  • 4Ros PR, Yuschok JJ, Buck JL, et al. Peritoneal masothelioma radio logic appearances co rrelated with histology [ J ]. Acta Radidogica, 1991,32:355.
  • 5Loggie BW. Malignant peritoneal mesothelioma [ J ]. Curr Treat Options Oncol,2001,2 :395 - 399.
  • 6Sugarbaker PH, Acherman YI, Gonzalez MS, et al. Diagnosis and treatment of peritoneal mesothelioma: The Washington Cancer Institute experience [ J ]. Semin Oncol, 2002,29:51 - 61.
  • 7Janne PA, Wozniak A j, Belani CP, et al. Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma : outcomes of an expanded access program[J]. Clin Lung Cancer, 2005,7( 1 ) :40 -46.

同被引文献81

引证文献9

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部